Barbara Corcoran’s credits include straight D’s in high school and college and 20 jobs by the time she turned 23. It was her next job that would make her one of the most successful entrepreneurs in the country: She borrowed $1,000 and quit her job as a waitress to start a tiny real estate company in New York City. Over the next 25 years, Corcoran would parlay that $1,000 loan into a $5 billion real estate business, building the largest and best-known brand in the business.
Corcoran is the author of the best seller “Shark Tales: How I Turned $1,000 into a Billion Dollar Business!” and host of top business podcast “Business Unusual with Barbara Corcoran.”
Corcoran is a motivational and inspirational speaker. She is a frequent small business and real estate contributor on every major network. Corcoran has been an investor/Shark for the past nine seasons on ABC’s four-time Emmy award winning show, Shark Tank, investing in over 80 businesses to date. Follow her on Twitter and Instagram @BarbaraCorcoran.
John Sganga is responsible for the overall leadership of Premier’s nonacute, alternate site, sponsor of affiliate, and e-commerce programs.
Prior to Premier, Sganga launched and served as President and CEO of Innovatix and Essensa, which Premier acquired in Dec. 2016. Under his leadership, Innovatix and Essensa have grown into leading national non-acute care GPOs, with over 60,000 members and surpassing $8.2 billion in combined contract volume in 2016.
Sganga’s nearly 30 years of healthcare experience includes serving as executive vice president of GNYHA Ventures (the business arm of the Greater New York Hospital Association), senior director of financial operations at Columbia-Presbyterian Medical Center, and at Ernst & Young’s Management Consulting Service. He provided leadership on the Executive Board of the Metropolitan Health Administrators’ Association (MHAA) for 17 years and received the 2004 Award of Distinction for his commitment to healthcare. Sganga is a fellow of the American College of Healthcare Executives (ACHE) and currently serves on the White Plains Hospital Board of Directors.
In 1999, Sganga was recognized as one of Crain’s New York Business “40 Under Forty,” and was also awarded the New York University Alumni Torch Award for public service. In 2008, he was a finalist for the Ernst & Young Entrepreneur of the Year Award, New York Metro Area Healthcare Division.
Sganga holds a master’s in public administration from the Robert F. Wagner Graduate School of Public Service at New York University, with a concentration in financial management.
As Senior Vice President of Public Affairs for Premier, Blair Childs is the primary spokesperson and communications strategist for the organization on key issues impacting healthcare costs and quality. Childs is a respected and well-recognized expert on health policy and advocacy, and has appeared on all the major television networks, as well as been quoted in most national publications. He serves as liaison to the U.S. Congress, White House, healthcare policymakers and other major bodies involved in healthcare policy and regulation.
With partisan politics heating up in Washington, D.C., Mr. Childs will deliver an inside look at the health policies in play for the Administration as well as the 116th Congress as they race to finish their legislative work before they adjourn for the year. He will examine key issues for healthcare providers and business owners as we head into the 2020 elections, including predictions on different scenarios that may unfold. Finally, he will discuss Premier’s ongoing efforts to influence policy on behalf of our non-acute providers and position their value in the continuum of care.
Aaron Tucker is a Navy SEAL combat veteran with deployments to seven countries. Upon leaving the SEAL Teams, Tucker turned his discipline and battlefield lessons to the world of business. He is an accomplished entrepreneur, consultant, and acclaimed speaker on topics ranging from leadership and building high-performance teams to culture and organizational transformation.
Tucker is an executive with his own progressive leadership and management consulting firm, focusing on business transformation and building high-performance cultures. With a degree in marketing and advanced degrees in business and management, Tucker’s experience is both academic and real-world in nature, from working with world renowned behavioral and clinical psychologists to engaging with the US Navy to create a shift in operational effectiveness and training.
Tucker has a passion for life and challenges himself and others by following specific rules for success. He has summited Kilimanjaro, participated in expedition length adventure racing as a sponsored athlete, and is completing a Ph.D. in Management with work in leading developing teams.
Manju T. Beier is President and founder of Geriatric Consultant Resources LLC. She has extensive experience targeting complex polypharmacy issues and addressing medication management in older adults. She is also Adjunct Clinical Associate Professor of Pharmacy at the University of Michigan, Ann Arbor, and a Board-Certified Geriatric Pharmacist.
Dr. Beier has been serving on the national Epocrates Senior Clinical Board since 2011 as the only pharmacist with expertise in geriatrics. Her experience in drug-drug and drug-gene interactions make her uniquely qualified in the domain of personalized medicine, pharmacogenomics, and polypharmacy.
Dr. Beier has served two terms on the Board of the American Society of Consultant Pharmacists (ASCP), where she chairs the Deprescribing Task Force. She is the 2006 recipient of the prestigious George F. Archambault Award, which is ASCP’s highest honor.
Medication Safety Considerations: What’s the Buzz about Deprescribing?
Much has been written and discussed about polypharmacy in older adults and the potential for harm, including the risk for adverse drug reactions and potentially avoidable hospitalizations. We need to constantly reevaluate what we prescribe and monitor for safety and effectiveness. Our actions or inactions in this regard can lead to unintended consequences precipitating functional decline and decreased quality of life in our patients and residents.
“Deprescribing” identifies medications that don’t match up with the patient’s goals of care, that are too costly, or that are no longer needed. This session focuses on how to revisit our medication safety considerations as a healthcare team. After all, it’s not the number of medications that are the enemy, but careless and inappropriate prescribing.
Susan Catalano is the Managing Partner of JQLaCorte, a full service LinkedIn consultancy providing comprehensive LinkedIn-based marketing, business development, and employee advocacy programs for businesses. She consults with companies and professional services firms on the innovative use of LinkedIn to achieve measurable business results such as generating leads, boosting SEO results, improving visibility to clients and prospects, and promoting staff expertise.
Susan Catalano has over 15 years of experience in talent management for Fortune 500 corporations, as well as sales and marketing programs for companies and individual business owners. She regularly presents to national organizations and corporate and business audiences.
Robert Clark is Managing Principal of LucidPointe, a boutique digital agency specializing in online marketing, email marketing, marketing automation, and business automation strategy and execution. He has over 30 years of experience advising businesses from SMB to Fortune 50 companies, nonprofits, associations, and industry groups on marketing, sales, operations, strategy, and information technology.
Robert Clark regularly presents to national organizations and companies of all sizes.
Dr. Liya Davydov is Vice President of Clinical Pharmacy Services at Innovatix. She is responsible for clinical pharmacy services for Innovatix members across all healthcare classes of trade. In addition to coordinating all member educational programs, Dr. Davydov developed and maintains the web-based Drug Intelligence Program, keeping members and staff apprised on newly approved drugs, drugs going off patent, and upcoming drugs in the pipeline.
Prior to joining Innovatix, Dr. Davydov worked as a Clinical Pharmacy Manager at Fidelis Care New York, a managed Medicaid HMO. She previously held a Clinical Pharmacy Manager position at St. John’s Episcopal Hospital. Dr. Davydov earned both her degrees, BS in Pharmacy and Doctor of Pharmacy, from St. John’s University. She also completed an ASHP-accredited Pharmacy Practice Residency at Mount Sinai Medical Center in New York, is Board Certified in Pharmacotherapy, and is also a Board Certified Geriatric Pharmacist.
Andrea Hershatter is Senior Associate Dean and Director of the BBA Program in Emory’s Goizueta Business School. She has led this program for over two decades and helped to achieve its nine consecutive BusinessWeek rankings in the top 10, a distinction held by only four undergraduate business programs in the world.
Hershatter holds a faculty position in the Organization and Management area, where she teaches entrepreneurship, incorporating business model canvas, and design thinking approaches. Her research focuses on creativity and innovation, passions she combines with a strong interest in popular culture and music. She regularly consults with corporations and academia on the millennial generation and is a frequent presenter on the topics of entrepreneurship, generational attitudes and workplace culture, and management education.
Dr. Christopher M. Jones serves as Senior Advisor and Director of Strategy and Innovation in the CDC Injury Center. In this role, he focuses on research, policy, and strategy related to a broad range of injury and violence topics including drug overdose, suicide, and adverse childhood experiences.
Prior to joining CDC, he served as the first Director of the National Mental Health and Substance Use Policy Laboratory at the Substance Abuse and Mental Health Services Administration. He has also served in leadership roles in the Office of the Assistant Secretary for Planning and Evaluation at HHS and the Office of the Commissioner at the FDA.
Jones received his BS degree from Reinhardt College, his PharmD degree from Mercer University, his MPH degree from New York Medical College, and his DrPH degree in health policy from The George Washington University.
Patricia Kienle is the Director of Accreditation and Medication Safety for Cardinal Health Innovative Delivery Solutions. She has served on the Board of Directors of the American Society of Health-System Pharmacists, where she is a Fellow, and as President of the Pennsylvania Society of Hospital Pharmacists. Among her awards and honors are the ASHP Distinguished Leadership Award and PSHP Pharmacist of the Year. She is a current member of the USP Compounding Expert Committee and chairs the Subcommittee on Hazardous Drugs.
The author of numerous publications on pharmacy safety, including The Chapter Answer Book, Kienle received her pharmacy degree from the Philadelphia College of Pharmacy and Science, and an MPA from Marywood University. She completed an Executive Fellowship in Patient Safety from Virginia Commonwealth University and is an Adjunct Associate Professor at Wilkes University.
With over 500 invited presentations and 80 publications, Kienle has special interest in promoting medication safety, compounding sterile preparations, accreditation, and regulatory issues.
Brad Kile is president of the Dumbarton Group, LLC, where he provides services to non-profit and corporate entities to assist them in navigating health care legislative and regulatory policy changes. He is active at both the federal and state levels as an advocate in the areas of healthcare access, long-term care, and government-funded prescription medication benefits. He has extensive knowledge of state-level policies and the implications of federal policies on the development and delivery of state-based healthcare.
Dr. Kile received his PhD in healthcare policy from Florida State University. He earned a bachelor’s degree from James Madison University and a master’s degree from the American University in Washington, DC.
Shifting Provider Reimbursement: The Latest on Medicare Part D and Post-Acute Care
Provider reimbursements have undergone major shifts in recent years with the implementation of the Affordable Care Act (ACA) and commercial market changes. During this session, we will explore the financial and operational challenges presented by the convergence of political and market forces driving provider reimbursements toward quality and outcomes-based measures.
After an overview of recent Medicare and Medicaid developments in Congress, we will examine key regulatory action on Post-Acute Care (PAC) and Part D from the Trump Administration. The session includes an in-depth look at the Skilled Nursing Facility (SNF) Patient Driven Payment Model implementation for October 2019, and structural changes for Part D in 2019 and 2020. Participants will learn about navigating the changing market to adapt to new reimbursement incentives.
Andrew Orr-Skirvin has been a faculty member for 25 years, teaching pharmacy students and providing clinical services to oncology patients. Dr. Orr-Skirvin’s interest areas include adult oncology and hematology patient care. In particular, he focuses on supportive care for oncology patients, including pain management, symptom control, and minimizing toxicity.
Dr. Orr-Skirvin attended Oregon State University, where he earned his Bachelor of Science in Pharmacy, and the University of Texas Health Science Center in San Antonio, where he earned his Doctor of Pharmacy from the University of Texas at Austin. He completed an oncology pharmacy residency at the Audie Murphy Veterans Hospital in San Antonio.
Vice President, Government Affairs, National Home Infusion Association
Sharon Pearce is a seasoned Washington veteran, having worked in the health policy arena for more than 20 years. Following six years on Capitol Hill, where she advised Members of Congress on health policy and other issues, Pearce joined a prominent K Street law firm where she represented Fortune 500 companies, voluntary health associations, hospitals and health systems, and trade associations. More recently, Pearce has led the government relations activities of the Girl Scouts of the USA, the National PACE Association, and the National Hospice and Palliative Care Organization.
Alan G. Rosenbloom serves as president and CEO of the Senior Care Pharmacy Coalition (SCPC), the only trade group in Washington dedicated exclusively to the political and public policy interests of long-term care pharmacies. He helped a small group of pharmacies create the SCPC in October 2014. During his tenure, SCPC influenced numerous policy decisions benefitting long-term care pharmacies and patients.
Rosenbloom has spent his entire professional career in healthcare, including stints as president of the Alliance for Quality Nursing Home Care, president and CEO of the Pennsylvania Health Care Association and acting president, EVP and COO of LeadingAge. He began his career as a healthcare lawyer in Philadelphia, with a focus on representing long-term care providers.
Rosenbloom received a JD from the University of Pennsylvania, where he served as associate editor of the Law Review, and also studied public policy at the Wharton School. He received his undergraduate degree from the University of Massachusetts.
Soumi Saha serves as the Senior Director of Advocacy at Premier, where she is responsible for influencing legislative and regulatory proposals that support a competitive drug marketplace and lead the transformation to high-quality, cost-effective healthcare.
Saha previously held positions as the Director of Pharmacy & Regulatory Affairs at the Academy of Managed Care Pharmacy (AMCP) and the Director of National Pharmacy Controls at Kaiser Permanente. She has a Doctor of Pharmacy (PharmD) from the University of Maryland School of Pharmacy and a Juris Doctor (JD) with a concentration in Health Law from the University of Maryland School of Law.
Joseph Saseen is Professor of Clinical Pharmacy and Vice Chair of Clinical and Academic Programs for the Department of Clinical Pharmacy at the University of Colorado Anschutz Medical Campus. He is also a Professor of Family Medicine and practices as a clinical pharmacist, focusing on chronic disease state management, cardiovascular risk reduction, and population health. Dr. Saseen teaches cardiovascular pharmacotherapy and is the PGY2 Ambulatory Care residency program director.
Dr. Saseen is a Board Certified Pharmacotherapy Specialist, a Board Certified Ambulatory Care Pharmacist, and a Clinical Lipid Specialist. He is currently President Elect of the National Lipid Association and is chair of the Education Council. He was also recipient of the NLA Presidents Service Award in 2018.
Dr. Saseen has received several teaching awards, most recently the 2016 American Association of Colleges of Pharmacy Teaching Innovations award. His scholarly work includes over 120 peer-reviewed publications.
Merging two passions, data research and mystery shopping, Lisa van Kesteren has forged a new path with SeeLevel HX. This premier mystery shopping agency utilizes over 792,000 gig workers to help brands improve their customer experiences.
Previously, van Kesteren founded Mystery Researchers in 2008, leveraging her extensive customer experience background, which includes the establishment and growth of two of the largest customer experience/data research companies in the industry. Additionally, she was a founding member of the Mystery Shopping Providers Association, where she served as the chairperson of the professionalism and ethics committee and was responsible for creating the industry’s original code of ethics.
In 2018, van Kesteren was honored with the March of Dimes Atlanta Woman of Distinction award and was also inducted into the EY Entrepreneurial Winning Women™ Class of 2018.
Emily H. Wein is of counsel and a health care lawyer with Foley & Lardner LLP, and member of the firm’s national Telemedicine & Digital Health Industry Team. Within the telehealth and digital health space, she focuses on fraud and abuse compliance, Medicare and Medicaid enrollment/claims submission, compliance with Conditions of Participation, and medical staff credentialing and privileging. She is also a Clear Health Quality Institute (CHQI) recognized consultant for its Telemedicine Accreditation Program, with the experience and training necessary to help companies through the accreditation process.
Previously, Wein spent five years as in-house counsel at a nationally-known academic medical center health system, where she led the development of its virtual care service programs, including tele-stroke and tele-cardiology.
Chad Worz is the executive director and chief operating officer of the American Society of Consultant Pharmacists (ASCP).
A graduate of the University of Cincinnati College of Pharmacy, Worz’s career has focused on the medication management of older adults. He has practiced extensively in skilled nursing environments on psychoactive medication management. Worz developed an innovative clinical practice in a long-term care setting in Ohio and directed the pharmacy practice of a regional, independent pharmacy serving 10,000 long-term care residents.
Worz established his geriatric-based consulting company, Medication Managers, LLC, to educate and serve nursing facility residents, nursing facility administration, long-term care pharmacies, and the public through a comprehensive knowledge of medication use. He has presented nationally on a myriad of medication related topics and served on a number of national boards related to pharmacy and medication utilization.